Global Interventional Oncology Device Market Research Report 2021

1 Interventional Oncology Device Market Overview

• 1.1 Product Overview and Scope of Interventional Oncology Device
• 1.2 Interventional Oncology Device Segment by Type
  • 1.2.1 Global Interventional Oncology Device Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Ablation Devices
  • 1.2.3 Embolization Devices
  • 1.2.4 Supporting Devices
  • 1.2.5 Next Generation Devices
• 1.3 Interventional Oncology Device Segment by Application
  • 1.3.1 Interventional Oncology Device Sales Comparison by Application: (2021-2027)
  • 1.3.2 Hospitals
  • 1.3.3 Specialty Clinics and Ambulatory Surgical Centers
  • 1.3.4 Others (Homecare and Research Institutes)
• 1.4 Global Interventional Oncology Device Market Size Estimates and Forecasts
  • 1.4.1 Global Interventional Oncology Device Revenue 2016-2027
  • 1.4.2 Global Interventional Oncology Device Sales 2016-2027
  • 1.4.3 Interventional Oncology Device Market Size by Region: 2016 Versus 2021 Versus 2027

2 Interventional Oncology Device Market Competition by Manufacturers

• 2.1 Global Interventional Oncology Device Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Interventional Oncology Device Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Interventional Oncology Device Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Interventional Oncology Device Manufacturing Sites, Area Served, Product Type
• 2.5 Interventional Oncology Device Market Competitive Situation and Trends
  • 2.5.1 Interventional Oncology Device Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Interventional Oncology Device Players Market Share by Revenue
  • 2.5.3 Global Interventional Oncology Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Interventional Oncology Device Retrospective Market Scenario by Region

• 3.1 Global Interventional Oncology Device Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Interventional Oncology Device Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Interventional Oncology Device Market Facts & Figures by Country
  • 3.3.1 North America Interventional Oncology Device Sales by Country
  • 3.3.2 North America Interventional Oncology Device Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Interventional Oncology Device Market Facts & Figures by Country
  • 3.4.1 Europe Interventional Oncology Device Sales by Country
  • 3.4.2 Europe Interventional Oncology Device Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Interventional Oncology Device Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Interventional Oncology Device Sales by Region
  • 3.5.2 Asia Pacific Interventional Oncology Device Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Interventional Oncology Device Market Facts & Figures by Country
  • 3.6.1 Latin America Interventional Oncology Device Sales by Country
  • 3.6.2 Latin America Interventional Oncology Device Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Interventional Oncology Device Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Interventional Oncology Device Sales by Country
  • 3.7.2 Middle East and Africa Interventional Oncology Device Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Interventional Oncology Device Historic Market Analysis by Type

• 4.1 Global Interventional Oncology Device Sales Market Share by Type (2016-2021)
• 4.2 Global Interventional Oncology Device Revenue Market Share by Type (2016-2021)
• 4.3 Global Interventional Oncology Device Price by Type (2016-2021)

5 Global Interventional Oncology Device Historic Market Analysis by Application

• 5.1 Global Interventional Oncology Device Sales Market Share by Application (2016-2021)
• 5.2 Global Interventional Oncology Device Revenue Market Share by Application (2016-2021)
• 5.3 Global Interventional Oncology Device Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 AngioDynamics, Inc.
  • 6.1.1 AngioDynamics, Inc. Corporation Information
  • 6.1.2 AngioDynamics, Inc. Description and Business Overview
  • 6.1.3 AngioDynamics, Inc. Interventional Oncology Device Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 AngioDynamics, Inc. Product Portfolio
  • 6.1.5 AngioDynamics, Inc. Recent Developments/Updates
• 6.2 BD
  • 6.2.1 BD Corporation Information
  • 6.2.2 BD Description and Business Overview
  • 6.2.3 BD Interventional Oncology Device Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 BD Product Portfolio
  • 6.2.5 BD Recent Developments/Updates
• 6.3 Boston Scientific Corporation
  • 6.3.1 Boston Scientific Corporation Corporation Information
  • 6.3.2 Boston Scientific Corporation Description and Business Overview
  • 6.3.3 Boston Scientific Corporation Interventional Oncology Device Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Boston Scientific Corporation Product Portfolio
  • 6.3.5 Boston Scientific Corporation Recent Developments/Updates
• 6.4 BTG Plc
  • 6.4.1 BTG Plc Corporation Information
  • 6.4.2 BTG Plc Description and Business Overview
  • 6.4.3 BTG Plc Interventional Oncology Device Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 BTG Plc Product Portfolio
  • 6.4.5 BTG Plc Recent Developments/Updates
• 6.5 Eckert & Ziegler BEBIG
  • 6.5.1 Eckert & Ziegler BEBIG Corporation Information
  • 6.5.2 Eckert & Ziegler BEBIG Description and Business Overview
  • 6.5.3 Eckert & Ziegler BEBIG Interventional Oncology Device Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Eckert & Ziegler BEBIG Product Portfolio
  • 6.5.5 Eckert & Ziegler BEBIG Recent Developments/Updates
• 6.6 HealthTronics, Inc.
  • 6.6.1 HealthTronics, Inc. Corporation Information
  • 6.6.2 HealthTronics, Inc. Description and Business Overview
  • 6.6.3 HealthTronics, Inc. Interventional Oncology Device Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 HealthTronics, Inc. Product Portfolio
  • 6.6.5 HealthTronics, Inc. Recent Developments/Updates
• 6.7 IceCure Medical
  • 6.6.1 IceCure Medical Corporation Information
  • 6.6.2 IceCure Medical Description and Business Overview
  • 6.6.3 IceCure Medical Interventional Oncology Device Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 IceCure Medical Product Portfolio
  • 6.7.5 IceCure Medical Recent Developments/Updates
• 6.8 Medtronic PLC
  • 6.8.1 Medtronic PLC Corporation Information
  • 6.8.2 Medtronic PLC Description and Business Overview
  • 6.8.3 Medtronic PLC Interventional Oncology Device Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Medtronic PLC Product Portfolio
  • 6.8.5 Medtronic PLC Recent Developments/Updates
• 6.9 Medwaves, Inc.
  • 6.9.1 Medwaves, Inc. Corporation Information
  • 6.9.2 Medwaves, Inc. Description and Business Overview
  • 6.9.3 Medwaves, Inc. Interventional Oncology Device Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 Medwaves, Inc. Product Portfolio
  • 6.9.5 Medwaves, Inc. Recent Developments/Updates
• 6.10 Merit Medical Systems, Inc.
  • 6.10.1 Merit Medical Systems, Inc. Corporation Information
  • 6.10.2 Merit Medical Systems, Inc. Description and Business Overview
  • 6.10.3 Merit Medical Systems, Inc. Interventional Oncology Device Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Merit Medical Systems, Inc. Product Portfolio
  • 6.10.5 Merit Medical Systems, Inc. Recent Developments/Updates
• 6.11 Sanarus Technologies, Inc.
  • 6.11.1 Sanarus Technologies, Inc. Corporation Information
  • 6.11.2 Sanarus Technologies, Inc. Interventional Oncology Device Description and Business Overview
  • 6.11.3 Sanarus Technologies, Inc. Interventional Oncology Device Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 Sanarus Technologies, Inc. Product Portfolio
  • 6.11.5 Sanarus Technologies, Inc. Recent Developments/Updates
• 6.12 Sirtex Medical Ltd.
  • 6.12.1 Sirtex Medical Ltd. Corporation Information
  • 6.12.2 Sirtex Medical Ltd. Interventional Oncology Device Description and Business Overview
  • 6.12.3 Sirtex Medical Ltd. Interventional Oncology Device Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 Sirtex Medical Ltd. Product Portfolio
  • 6.12.5 Sirtex Medical Ltd. Recent Developments/Updates
• 6.13 Sonacare Medical
  • 6.13.1 Sonacare Medical Corporation Information
  • 6.13.2 Sonacare Medical Interventional Oncology Device Description and Business Overview
  • 6.13.3 Sonacare Medical Interventional Oncology Device Sales, Revenue and Gross Margin (2016-2021)
  • 6.13.4 Sonacare Medical Product Portfolio
  • 6.13.5 Sonacare Medical Recent Developments/Updates
• 6.14 Terumo Corporation
  • 6.14.1 Terumo Corporation Corporation Information
  • 6.14.2 Terumo Corporation Interventional Oncology Device Description and Business Overview
  • 6.14.3 Terumo Corporation Interventional Oncology Device Sales, Revenue and Gross Margin (2016-2021)
  • 6.14.4 Terumo Corporation Product Portfolio
  • 6.14.5 Terumo Corporation Recent Developments/Updates
• 6.15 Trod Medical
  • 6.15.1 Trod Medical Corporation Information
  • 6.15.2 Trod Medical Interventional Oncology Device Description and Business Overview
  • 6.15.3 Trod Medical Interventional Oncology Device Sales, Revenue and Gross Margin (2016-2021)
  • 6.15.4 Trod Medical Product Portfolio
  • 6.15.5 Trod Medical Recent Developments/Updates
• 6.16 Cook Meidical LLC
  • 6.16.1 Cook Meidical LLC Corporation Information
  • 6.16.2 Cook Meidical LLC Interventional Oncology Device Description and Business Overview
  • 6.16.3 Cook Meidical LLC Interventional Oncology Device Sales, Revenue and Gross Margin (2016-2021)
  • 6.16.4 Cook Meidical LLC Product Portfolio
  • 6.16.5 Cook Meidical LLC Recent Developments/Updates

7 Interventional Oncology Device Manufacturing Cost Analysis

• 7.1 Interventional Oncology Device Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Interventional Oncology Device
• 7.4 Interventional Oncology Device Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Interventional Oncology Device Distributors List
• 8.3 Interventional Oncology Device Customers

9 Interventional Oncology Device Market Dynamics

• 9.1 Interventional Oncology Device Industry Trends
• 9.2 Interventional Oncology Device Growth Drivers
• 9.3 Interventional Oncology Device Market Challenges
• 9.4 Interventional Oncology Device Market Restraints

10 Global Market Forecast

• 10.1 Interventional Oncology Device Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Interventional Oncology Device by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Interventional Oncology Device by Type (2022-2027)
• 10.2 Interventional Oncology Device Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Interventional Oncology Device by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Interventional Oncology Device by Application (2022-2027)
• 10.3 Interventional Oncology Device Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Interventional Oncology Device by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Interventional Oncology Device by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List